Henry Schein, Inc. (HSIC) Earnings Call Transcripts

Henry Schein, Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of 2026, Henry Schein, Inc. reported global sales of $3.5 billion, reflecting a 6.7% increase year-over-year, driven by strong internal local currency sales growth of 4.6%. Non-GAAP earnings per share (EPS) rose to $1.27, a 15.5% increase compared to the previous year. Management raised its full-year 2026 guidance for total sales growth to a range of 4.5% to 5.5%, up from 3% to 5%, while maintaining EPS guidance in the range of $5.29 to $5.39, reflecting a growth of 6% to 8%. This indicates confidence in sustained operational momentum and margin improvements.

Reported metrics

Guidance from management

Management raised its full-year 2026 sales growth guidance to 4.5%-5.5% and non-GAAP diluted EPS guidance to $5.29-$5.39, reflecting stronger underlying sales performance and operational momentum.

What management said

Yes. I'll take the first part and I'll let Ron talk about the digital piece. But yes, yes, you're exactly right. We did have some tougher comps in -- we expect to see growth in the next 2 quarters in equipment, and our bookings look strong, and we feel good about seeing that business grow for the second half of the year. So just on the split between digital and nondigital, I'll let Ron take that.

Yes. I think a market issue, the market difference in the U.S. versus in EMEA, and I think the market in the U.S. is more consumer likes as it relates to implants relative to what you see in EMEA. So we believe we took share in the U.S. market. But in the quarter, that is for our premium implants, and frankly, for implants in general, but the market is just not growing as fast in the U.S. as it is in EMEA.

What analysts pressed on

Analysts expressed concerns about the U.S. dental equipment sales decline and whether the company can sustain growth in the face of tougher comparisons in the second half of the year. Questions were raised regarding the potential impact of pricing strategies and market dynamics on future performance.

Main topics on the call

• Revenue Growth Acceleration — Henry Schein experienced strong sales performance with global sales of $3.5 billion, representing a 6.7% increase year-over-year. CEO Fred Lowery noted, "Internal local currency sales growth accelerated compared to the f...
• Margin Improvement — The company reported a GAAP operating margin of 4.94%, up 27 basis points year-over-year, and a non-GAAP operating margin of 7.21%, an increase of 25 basis points. This improvement is attributed to gross margin expansion...
• Value Creation Initiatives — Management reiterated their commitment to achieving at least $200 million in operating income improvements from value creation initiatives over the next few years. CFO Ron South stated, "We expect to see initial benefits...
• Guidance Update — Henry Schein raised its full-year 2026 sales growth guidance to 4.5%-5.5%, up from 3%-5%. Non-GAAP diluted EPS guidance was also raised to $5.29-$5.39, reflecting stronger underlying expected sales performance, as noted ...

Read the full Henry Schein, Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 113 Henry Schein, Inc. earnings call transcripts on record, spanning January 15, 2020 to August 4, 2026. Based on this history, Henry Schein, Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

HSIC

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

113

First call

January 15, 2020

Most recent

August 4, 2026

Reporting cadence

quarterly